Amanote Research
Register
Sign In
OA10.05 an Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients With Uncommon EGFR Mutation(KCSG-Lu15-09)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.291
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
J.H. Cho
J. Sun
S. Lee
J.S. Ahn
K. Park
K.U. Park
E.J. Kang
Y.H. Choi
K.H. Kim
H.J.A. An
H.W. Lee
M. Ahn
Publisher
Elsevier BV